Water-compatible molecularly imprinted polymer for the selective recognition of fluoroquinolone antibiotics in biological samples

Benito-Peña, Elena; Martins, Sofia; Orellana, Guillermo; Moreno-Bondi, María Cruz
January 2009
Analytical & Bioanalytical Chemistry;Jan2009, Vol. 393 Issue 1, p235
Academic Journal
A novel water-compatible molecularly imprinted polymer (MIP), prepared with enrofloxacin (ENR) as the template, has been optimised for the selective extraction of fluoroquinolone antibiotics in aqueous media. The results of a morphological characterisation and selectivity tests of the polymer material for ENR and related derivatives are reported. High affinity for the piperazine-based fluoroquinolones marbofloxacin, ciprofloxacin, norfloxacin and ofloxacin was observed, whereas no retention was found for nonrelated antibiotics. Various parameters affecting the extraction efficiency of the polymer have been optimised to achieve selective extraction of the antibiotics from real samples and to reduce nonspecific interactions. These findings resulted in a MISPE/HPLC-FLD method allowing direct extraction of the analytes from aqueous samples with a selective wash using just 50% (v/v) organic solvent. The method showed excellent recoveries and precision when buffered urine samples fortified at five concentration levels (25–250 ng mL−1 each) of marbofloxacin, ciprofloxacin, norfloxacin, enrofloxacin and sarafloxacin were tested (53–88%, RSD 1–10%, n = 3). Moreover, the biological matrix of the aqueous samples did not influence the preconcentration efficiency of the fluoroquinolones on the MIP cartridges; no significant differences were observed between the recovery rates of the antibiotics in buffer and urine samples. The detection limits of the whole process range between 1.9 and 34 ng mL–1 when 5-mL urine samples are processed. The developed method has been successfully applied to preconcentration of norfloxacin in urine samples of a medicated patient, demonstrating the ability of the novel MIP for selective extraction of fluoroquinolones in urine samples.


Related Articles

  • Molecularly Imprinted Polymers for Selective Solid-Phase Extraction of Verapamil from Biological Fluids and Human Urine. Javanbakht, Mehran; Shaabani, Narges; Abdouss, Majid; Ganjali, Mohammad R.; Mohammadi, Ali; Norouzi, Parviz // Current Pharmaceutical Analysis;Aug2009, Vol. 5 Issue 3, p269 

    In this work, water-compatible molecularly imprinted polymers (MIPs) were prepared for fast, accurate and selective solid-phase extraction of verapamil (VPM) from complex matrices such as biological fluids and human urine followed by its UV spectroscopic determination at 278 nm. The effective...

  • A practical guide to the fluoroquinolones. D'Epiro, Peter; Cheng, Cynthia // Patient Care;1/15/2002, Vol. 36 Issue 1, p20 

    Presents an approach to the appropriate use of quinolones. Description of the anti-bacterial action of fluoroquinolones; Classification; Adverse effects.

  • New Classification and Update on the Quinolone Antibiotics. King, Dana E.; Malone, Robb; Lilley, Sandra H. // American Family Physician;5/1/2000, Vol. 61 Issue 9, p2741 

    Presents an update on quinolone antibiotics. Overview of fluoroquinolones; Classification of quinolones; Cost of fluoroquinolone therapy.

  • Fluoroquinolone misuse in ER creates concern. Pfeiffer, Naomi // Dermatology Times;Jul2001, Vol. 22 Issue 7, p1 

    Cites research findings on the misuse of fluoroquinolone antibiotics in emergency rooms. Inappropriate dispensing of the antibiotic to patients; Impact of antibiotic misuse on the emergence of fluoroquinolone resistance; Need for a more vigorous campaign to educate physicians.

  • Fluoroquinolones in Paediatrics. Gendrel, D.; Moulin, F. // Pediatric Drugs;2001, Vol. 3 Issue 5, p365 

    The fluoroquinolones are an important group of antibiotics, which are widely used in adult patients because of their high penetration in tissues and bactericidal activity. However, they are not licensed for paediatric use (except the limited indication of Pseudomonas infection in cystic...

  • OVERVIEW OF THE FLUOROQUINOLONES focus on moxifloxacin. Andriole, Vincent T. // Managed Healthcare Executive;Jun2002 Supplement 1, Vol. 12 Issue 6, p13 

    Investigates the properties and clinical capabilities of fluoroquinolones or quinolones antibacterial agents. Historical background; Differentiation between the generations of quinolones; Details on structure and properties of the fluoroquinolones antibiotic moxifloxacin.

  • Clinical Q & A. Nathan, Joseph P. // Drug Topics;2/1/99, Vol. 143 Issue 3, p35 

    Provides information on the differences of fluoroquinolone antibiotics. Characteristics of some quinolones; Significance of close monitoring of the international normalized ratio; Advantages and disadvantages of different type of fluoroquinolone.

  • quinolone.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1957 

    A definition of the term "quinolone," which refers to any of a class of antibiotics that inhibit bacterial DNA gyrase, is presented.

  • Impact of Quinolone Restriction on Resistance Patterns of Escherichia coli Isolated from Urine by Culture in a Community Setting. Gottesman, Bat Sheva; Carmeli, Yehuda; Shitrit, Pnina; Chowers, Michal // Clinical Infectious Diseases;9/15/2009, Vol. 49 Issue 6, p869 

    Background. Decreased antimicrobial susceptibility after increased antibiotic use is a known phenomenon. Restoration of susceptibility once antimicrobial use is decreased is not self-evident. Our objective was to evaluate, in a community setting, the impact of quinolone restriction on the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics